miR-654-5p Targets HAX-1 to Regulate the Malignancy Behaviors of Colorectal Cancer Cells

被引:14
|
作者
Huang, Fuda [1 ]
Wu, Xianjian [2 ]
Wei, Mingwei [1 ]
Guo, Houji [1 ]
Li, Hua [1 ]
Shao, Zesheng [2 ]
Wu, Yi [2 ]
Pu, Jian [3 ]
机构
[1] Youjiang Med Univ Nationalities, Affiliated Hosp, Proctol Dept, Baise, Guangxi, Peoples R China
[2] Youjiang Med Univ Nationalities, Grad Coll, Baise, Guangxi, Peoples R China
[3] Youjiang Med Univ Nationalities, Dept Hepatobiliary Surg, Affiliated Hosp, Baise, Guangxi, Peoples R China
关键词
BREAST-CANCER; MICRORNAS; PROLIFERATION; METASTASIS; BIOMARKERS;
D O I
10.1155/2020/4914707
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Introduction. The biological roles of microRNA-654-5p (miR-654-5p) in cancers have been previously reported. However, its role in colorectal cancer (CRC) remains largely unknown. The purpose of this work was to investigate the roles and associated mechanisms in CRC. Methods. Quantitative Real-Time PCR (qRT-PCR) was utilized to explore the expression pattern of miR-654-5p in CRC cells. Cell Counting Kit-8 (CCK-8) assay, wound-healing assay, and transwell invasion assay were conducted to investigate the effects of miR-654-5p on CRC cell proliferation, migration, and invasion, respectively. Moreover, the mechanisms behind miR-654-5p regulates CRC progression were investigated. Results. Compared with normal cell line, miR-654-5p expression level was significantly suppressed in CRC cells. After overexpression of miR-654-5p, the malignancy behaviors of CRC cells including cell proliferation, migration, and invasion were remarkably decreased. Subsequently, we found hematopoietic cell-specific protein 1-associated protein X-1 (HAX-1) was a putative target for miR-654-5p. Rescue experiments showed overexpression of HAX-1 could partially reversed the effects of miR-654-4p on CRC cell events. Conclusion. miR-654-5p was reduced expression in CRC cells and could regulate CRC progression via targeting HAX-1.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Knockdown of Long Noncoding RNA01124 Inhibits the Malignant Behaviors of Colon Cancer Cells via miR-654-5p/HAX-1
    Wu, Yu-jin
    Cai, Zhi-quan
    He, Run-ming
    Wang, Xue-chuan
    Cong, Long-ling
    Qiu, Fang-hua
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [2] MiR-654-5p attenuates breast cancer progression by targeting EPSTI1
    Tan, Yu-Yan
    Xu, Xiao-Yun
    Wang, Jin-Feng
    Zhang, Cheng-Wu
    Zhang, Sheng-Chu
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (02): : 522 - 532
  • [3] The Clinical Value of Blood miR-654-5p, miR-126, miR-10b, and miR-144 in the Diagnosis of Colorectal Cancer
    Du, Gang
    Ren, Chongren
    Wang, Ju
    Ma, Jun
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [4] Expression and significance of miR-654-5p and miR-376b-3p in patients with colon cancer
    Li, Ping
    Cai, Jia-Xun
    Han, Fei
    Wang, Jie
    Zhou, Jia-Jie
    Shen, Kai-Wen
    Wang, Liu-Hua
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (04)
  • [5] miR-654-5p Contributes to the Activation and Proliferation of Hepatic Stellate Cells by Targeting RXRα
    Ma, Heming
    Wang, Xiaomei
    Liu, Xu
    Wang, Chang
    Gao, Xiuzhu
    Niu, Junqi
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [6] miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway
    Zhou, Weidong
    Li, Peifei
    Jin, Peihua
    OPEN MEDICINE, 2021, 16 (01): : 1683 - 1695
  • [7] Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells
    Liu, Jiajia
    Tang, Qinglai
    Li, Shisheng
    Yang, Xinming
    ONCOTARGET, 2016, 7 (52) : 86446 - 86456
  • [8] miR-654-5p Suppresses Migration and Proliferation of Vascular Smooth Muscle Cells by Targeting ADAMTS-7
    Li, Liu
    Wang, Shuo
    Wang, Ming
    Liu, Gang
    Yang, Zhiyu
    Wang, Le
    CELLS TISSUES ORGANS, 2023, 212 (04) : 285 - 292
  • [9] RETRACTION: miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway
    Zhou, Weidong
    Li, Peifei
    Jin, Peihua
    OPEN MEDICINE, 2025, 20 (01):
  • [10] miR-125b regulates the drug-resistance of breast cancer cells to doxorubicin by targeting HAX-1
    Hui, Guinv
    Zhao, Xiaokang
    Wang, Jiang
    Lv, Liting
    Wang, Chaoqun
    Feng, Liang
    Shen, Liangqiong
    Ren, Weili
    ONCOLOGY LETTERS, 2018, 15 (02) : 1621 - 1629